Sleep, Recovery, and Inflammation

Evidence Review

Sleep in Healthy Adults: Howatson et al. 2012

Howatson et al. (PMID 22038497), published in the European Journal of Nutrition, conducted a randomized crossover trial with 20 healthy adults (mean age 27). Participants consumed 30 mL of Montmorency tart cherry juice concentrate twice daily (morning and evening) or a matched placebo for 7 days, with a 14-day washout between conditions. The primary outcome was urinary 6-sulfatoxymelatonin (a melatonin metabolite), measured over 48 hours. The cherry condition produced significantly higher melatonin levels (p < 0.05) compared to placebo. Actigraphy showed significant increases in total sleep time (+34 minutes), time in bed, and sleep efficiency in the cherry condition vs. placebo. The study is notable for using objective sleep measurement (wrist actigraphy) rather than self-report alone, and for demonstrating that the effect was mediated through the melatonin pathway. The crossover design with washout period is a strength. Limitations include the small sample size and the use of healthy sleepers rather than people with sleep complaints.

Sleep in Older Adults with Insomnia: Pigeon et al. 2010

Pigeon et al. (PMID 20438325), published in the Journal of Medicinal Food, enrolled 15 older adults (mean age 68) with chronic insomnia in a 2-week randomized crossover trial. Participants drank 8 oz of tart cherry juice or a control beverage each morning and evening. The primary outcome was wake time after sleep onset (WASO), measured by 2-week sleep diary. Tart cherry juice produced a significant reduction in WASO (p < 0.05) compared to control. The authors noted the effect magnitude was comparable to published valerian and melatonin supplement trials in similar populations. This study specifically targeted a symptomatic population (older adults with insomnia) rather than healthy sleepers, increasing the practical relevance. Limitations include the small sample, self-report sleep measurement, and short duration. The 2010 Journal of Medicinal Food publication predates the larger Howatson trial and together they establish a consistent sleep signal across populations and outcome measures.

Exercise Recovery — Strength: Bowtell et al. 2011

Bowtell et al. (PMID 21233776), published in Medicine & Science in Sports & Exercise, studied 10 well-trained male athletes in a crossover design. The exercise protocol — 10 sets of 10 leg extensions at 80% of 1RM — was specifically designed to induce significant eccentric muscle damage and delayed-onset muscle soreness (DOMS). Participants consumed 30 mL of Montmorency cherry concentrate twice daily for 7 days before and 2 days after the exercise session. The cherry group showed substantially less oxidative damage: protein carbonyl levels (a marker of oxidative stress) were 23.8% above baseline at 24 hours post-exercise in the cherry group, compared to 82.7% above baseline in the placebo group — a striking difference. Maximum voluntary isometric contraction (MVIC) recovery was also faster: the cherry group retained 90.9% of baseline strength at 24 hours and 92.9% at 48 hours, compared to 84.9% and 88.5% in the placebo group. The mechanism proposed is the antioxidant and COX-inhibiting activity of the anthocyanins attenuating the secondary inflammatory response that prolongs muscle damage after intense exercise.

Exercise Recovery — Intermittent Sports: Bell et al. 2016

Bell et al. (PMID 27455316), published in Nutrients, extended the recovery evidence to intermittent high-intensity exercise relevant to team sports. Sixteen semi-professional soccer players were randomized to Montmorency tart cherry concentrate or placebo for 8 days, with a simulated soccer match (the Loughborough Intermittent Shuttle Test) on day 5. The cherry group showed better recovery of MVIC, countermovement jump height, and agility at 24 and 48 hours post-match (p < 0.05 for most comparisons). DOMS ratings were lower in the cherry group. Importantly, the acute inflammatory marker IL-6 was significantly attenuated after the match in the cherry group compared to placebo. This study is notable for its ecological validity — the exercise protocol was designed to simulate real match conditions — and the inclusion of functional performance measures alongside soreness self-reports. Together with Bowtell 2011, it establishes that the benefit applies to both isolated strength exercise and multi-modal team sport exertion.

Gout Risk Reduction: Zhang et al. 2012

Zhang et al. (PMID 23023818), published in Arthritis & Rheumatism, used a case-crossover design to study 633 patients with physician-diagnosed gout who were followed for one year. In this design, each patient serves as their own control: researchers compared cherry intake in the 2-day period before a gout attack to intake during control periods. Cherry consumption was associated with a 35% lower risk of gout attack (OR 0.65, 95% CI: 0.50–0.85). Three or more servings of cherries in a 2-day window provided the greatest benefit. Cherry extract consumption alone reduced risk by 45% (OR 0.55). Combining cherries with allopurinol reduced risk by 75% (OR 0.25, p < 0.001). The effect was consistent across subgroups defined by sex, obesity, purine intake, alcohol use, and diuretic use. This is the largest and most robust clinical evidence on cherries and gout, and the 35% risk reduction is a substantial effect size for a dietary intervention. Limitations include self-reported cherry intake and the observational nature (though the case-crossover design substantially controls for confounding).

Uric Acid Reduction: Martin and Coles 2019

Martin and Coles (PMID 31037275), published in Current Developments in Nutrition, conducted a 4-week randomized crossover trial in 26 overweight or obese adults (BMI 25–35) — a population prone to hyperuricemia. Participants consumed 240 mL/day of 100% tart cherry juice or placebo. At the end of 4 weeks, serum uric acid was reduced by 19.2% in the cherry group vs. placebo (p < 0.05). High-sensitivity CRP (a marker of systemic inflammation) trended downward by 19.4% (p = 0.09, borderline significance). This study provides direct mechanistic evidence that tart cherry juice reduces circulating urate in humans, supporting the gout risk findings from Zhang et al. The overweight population was a deliberate choice, as these individuals tend to have higher urate levels and may benefit most.

Overall Evidence Assessment

Tart cherry sits in an unusually well-supported position for a whole food supplement. The sleep effects are backed by multiple RCTs with objective measurements and plausible mechanisms (melatonin content, tryptophan). The exercise recovery benefits have been replicated across different exercise modalities in trained athletes. The gout/uric acid data is strong epidemiologically and supported by a mechanistic clinical trial.

The main limitations are typical of food research: relatively small sample sizes, use of industry-funded concentrates in some studies, and the difficulty of blinding participants to a distinctive-tasting food. The evidence is strongest for exercise recovery and gout prevention; the sleep evidence is promising but based on smaller trials. Overall, this is a functional food with a meaningful evidence base — not a cure-all, but one of the better-substantiated dietary interventions across several domains simultaneously.